Itron (NASDAQ:ITRI) SVP Sells $446,536.44 in Stock

Itron, Inc. (NASDAQ:ITRI) SVP Christopher Ware sold 4,486 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $446,536.44. Following the sale, the senior vice president owned 31,806 shares in the company, valued at $3,165,969.24. This trade represents a 12.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Itron Trading Down 1.8%

Shares of ITRI stock traded down $1.84 during trading hours on Monday, hitting $97.70. 522,620 shares of the company were exchanged, compared to its average volume of 759,610. The firm has a market cap of $4.39 billion, a PE ratio of 15.01, a PEG ratio of 0.86 and a beta of 1.48. Itron, Inc. has a 1 year low of $88.57 and a 1 year high of $142.00. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. The firm has a fifty day moving average of $97.72 and a 200 day moving average of $109.93.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.19 by $0.27. The firm had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The firm’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Analysts expect that Itron, Inc. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ITRI. Johnson Rice raised shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a report on Monday, January 5th. Oppenheimer increased their target price on Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a report on Wednesday. Wall Street Zen downgraded Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Zacks Research cut Itron from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Finally, Argus reiterated a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Itron currently has a consensus rating of “Moderate Buy” and an average price target of $137.90.

Institutional Trading of Itron

Several large investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC lifted its position in Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares during the period. Amalgamated Bank lifted its holdings in shares of Itron by 0.7% in the third quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock valued at $1,627,000 after buying an additional 86 shares during the period. PFG Investments LLC lifted its holdings in shares of Itron by 4.8% in the third quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock valued at $256,000 after buying an additional 94 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after buying an additional 101 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC grew its holdings in Itron by 3.5% during the second quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after acquiring an additional 115 shares during the period. 96.19% of the stock is currently owned by institutional investors and hedge funds.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.